A citation-based method for searching scientific literature

Eduardo De Pablo-Fernandez, Raph Goldacre, Julia Pakpoor, Alastair J Noyce, Thomas T Warner. Neurology 2018
Times Cited: 112



Yu-Wan Yang, Teng-Fu Hsieh, Chia-Ing Li, Chiu-Shong Liu, Wen-Yuan Lin, Jen-Huai Chiang, Tsai-Chung Li, Cheng-Chieh Lin. Medicine (Baltimore) 2017
Times Cited: 62




List of shared articles



Times cited

Diabetes mellitus and Parkinson's disease: dangerous liaisons between insulin and dopamine.
Angela De Iuliis, Ennio Montinaro, Giuseppe Fatati, Mario Plebani, Carlo Colosimo. Neural Regen Res 2022
2

Repositioning and development of new treatments for neurodegenerative diseases: Focus on neuroinflammation.
Bruno Dutra Arbo, Lucia Emanueli Schimith, Michele Goulart Dos Santos, Mariana Appel Hort. Eur J Pharmacol 2022
0

Long-term hyperglycemia aggravates α-synuclein aggregation and dopaminergic neuronal loss in a Parkinson's disease mouse model.
Yi-Qing Lv, Lin Yuan, Yan Sun, Hao-Wen Dou, Ji-Hui Su, Zhi-Pan Hou, Jia-Yi Li, Wen Li. Transl Neurodegener 2022
1


Epidemiological Evidence for an Immune Component of Parkinson's Disease.
Paulina Gonzalez-Latapi, Connie Marras. J Parkinsons Dis 2022
0

The role of nutrition on Parkinson's disease: a systematic review.
Vittorio Emanuele Bianchi, Laura Rizzi, Fahad Somaa. Nutr Neurosci 2022
0

Parkinson's Disease and Sugar Intake-Reasons for and Consequences of a Still Unclear Craving.
Julienne Haas, Daniela Berg, Anja Bosy-Westphal, Eva Schaeffer. Nutrients 2022
0

Repurposing GLP-1 Receptor Agonists for Parkinson's Disease: Current Evidence and Future Opportunities.
Daniella Balduino Victorino, Mariana Nejm, Marcia Guimarães-Marques, Fulvio Alexandre Scorza, Carla Alessandra Scorza. Pharmaceut Med 2021
2

Euglycemia Indicates Favorable Motor Outcome in Parkinson's Disease.
Ioanna Markaki, Theodora Ntetsika, Kimmo Sorjonen, Per Svenningsson. Mov Disord 2021
10

Type 2 Diabetes as a Determinant of Parkinson's Disease Risk and Progression.
Harneek Chohan, Konstantin Senkevich, Radhika K Patel, Jonathan P Bestwick, Benjamin M Jacobs, Sara Bandres Ciga, Ziv Gan-Or, Alastair J Noyce. Mov Disord 2021
28

Prediabetes, type 2 diabetes mellitus and risk of Parkinson's disease: A population-based cohort study.
Almudena Sánchez-Gómez, Yesika Díaz, Talita Duarte-Salles, Yaroslau Compta, Maria José Martí. Parkinsonism Relat Disord 2021
5


Insulin-degrading enzyme: an ally against metabolic and neurodegenerative diseases.
Luís Sousa, Mariana Guarda, Maria João Meneses, M Paula Macedo, Hugo Vicente Miranda. J Pathol 2021
9


Diabetes Mellitus and Parkinson's Disease: A Systematic Review and Meta-Analyses.
Klara Komici, Grazia Daniela Femminella, Leonardo Bencivenga, Giuseppe Rengo, Gennaro Pagano. J Parkinsons Dis 2021
1

Investigation of the Possible Correlation between Idiopathic Parkinson's Disease and Diabetes Mellitus in Egyptian Patients: A Pilot Study.
Afnan AwadAllah Elgnainy, Mohammad Ismail Hamed, Wael Osman Mohamed, Nagwa Ali Sabri. Neurol Res Int 2021
0

Two Birds One Stone: The Neuroprotective Effect of Antidiabetic Agents on Parkinson Disease-Focus on Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors.
Kai-Jung Lin, Tzu-Jou Wang, Shang-Der Chen, Kai-Lieh Lin, Chia-Wei Liou, Min-Yu Lan, Yao-Chung Chuang, Jiin-Haur Chuang, Pei-Wen Wang, Jong-Jer Lee,[...]. Antioxidants (Basel) 2021
3

Understanding the links between cardiovascular disease and Parkinson's disease.
Judy Potashkin, Xuemei Huang, Claudia Becker, Honglei Chen, Thomas Foltynie, Connie Marras. Mov Disord 2020
38

Body mass index, diabetes, and the risk of Parkinson's disease.
Su-Min Jeong, Kyungdo Han, Dahye Kim, Sang Youl Rhee, Wooyoung Jang, Dong Wook Shin. Mov Disord 2020
29

The Association Between Type 2 Diabetes Mellitus and Parkinson's Disease.
Julia L Y Cheong, Eduardo de Pablo-Fernandez, Thomas Foltynie, Alastair J Noyce. J Parkinsons Dis 2020
41

Diabetes Causes Dysfunctional Dopamine Neurotransmission Favoring Nigrostriatal Degeneration in Mice.
Iara Pérez-Taboada, Samuel Alberquilla, Eduardo D Martín, Rishi Anand, Stefania Vietti-Michelina, Nchimunya N Tebeka, James Cantley, Stephanie J Cragg, Rosario Moratalla, Mario Vallejo. Mov Disord 2020
18

Lipid Metabolism is the common pathologic mechanism between Type 2 Diabetes Mellitus and Parkinson's disease.
Xi Zhang, Yu Fan, Yuping Luo, Lingjing Jin, Siguang Li. Int J Med Sci 2020
4

Diabetes Mellitus and Parkinson's Disease: Shared Pathophysiological Links and Possible Therapeutic Implications.
Abdallah Hassan, Rajan Sharma Kandel, Rohi Mishra, Jeevan Gautam, Amer Alaref, Nusrat Jahan. Cureus 2020
17

Neuroprotective Actions of Glucagon-Like Peptide-1 (GLP-1) Analogues in Alzheimer's and Parkinson's Diseases.
Andre F Batista, Victor Bodart-Santos, Fernanda G De Felice, Sergio T Ferreira. CNS Drugs 2019
33